- Report
- May 2024
- 180 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2024
- 186 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- June 2021
- 105 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Drug Pipelines
- August 2022
- 75 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Clinical Trials
- January 2021
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2023
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- October 2023
- 84 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- October 2023
- 91 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- August 2023
- 109 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- May 2022
- 56 Pages
Global
From €2386EUR$2,500USD£1,999GBP
Oxytocin is a hormone and medication used in the field of sexual and reproductive health. It is used to induce labor, reduce postpartum bleeding, and to support breastfeeding. It is also used to induce uterine contractions in women with an incomplete or threatened miscarriage. Oxytocin is available in both injectable and nasal spray forms.
Oxytocin is a key component of sexual and reproductive health drugs, as it is used to induce labor and reduce postpartum bleeding. It is also used to support breastfeeding and to induce uterine contractions in women with an incomplete or threatened miscarriage. Oxytocin is available in both injectable and nasal spray forms, and is used in a variety of settings, including hospitals, clinics, and home births.
Some companies in the Oxytocin market include Pfizer, Novartis, Merck, and Sanofi. Show Less Read more
